Zena-Huancas, P.; Leon-Jimenez, F.; Bryce-Alberti, M.; Portmann Baracco, Arianna Sibila
(Wolters Kluwer Health, 2021)
Based on the pathophysiological characterization of COVID-19, initial studies suggested the use of tocilizumab (TCZ), a recombinant humanized monoclonal antibody of the immunoglobulin G1 class, for management of the cytokine ...